The rationale for the aggressive progression of MASLD in patients with type 2 diabetes
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Annals of Hepatology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268125000043 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832540434645123072 |
|---|---|
| author | Valeria Michelle Fernández-Garibay Norberto C. Chavez-Tapia |
| author_facet | Valeria Michelle Fernández-Garibay Norberto C. Chavez-Tapia |
| author_sort | Valeria Michelle Fernández-Garibay |
| collection | DOAJ |
| format | Article |
| id | doaj-art-fdd71157210a4ee28f74cd071d8066ab |
| institution | Kabale University |
| issn | 1665-2681 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Annals of Hepatology |
| spelling | doaj-art-fdd71157210a4ee28f74cd071d8066ab2025-02-05T04:31:24ZengElsevierAnnals of Hepatology1665-26812025-01-01301101778The rationale for the aggressive progression of MASLD in patients with type 2 diabetesValeria Michelle Fernández-Garibay0Norberto C. Chavez-Tapia1Obesity and Digestive Disease Unit, Medica Sur Clinic and Foundation, Puente de Piedra 150, Toriello Guerra, 14050 Mexico City, MexicoCorresponding author.; Obesity and Digestive Disease Unit, Medica Sur Clinic and Foundation, Puente de Piedra 150, Toriello Guerra, 14050 Mexico City, Mexicohttp://www.sciencedirect.com/science/article/pii/S1665268125000043steatotic liver diseaseNAFLD (non-alcoholic fatty liver disease)NASH (non-alcoholic steatohepatitis)liver-related mortalityadverse-liver outcomesliver disease |
| spellingShingle | Valeria Michelle Fernández-Garibay Norberto C. Chavez-Tapia The rationale for the aggressive progression of MASLD in patients with type 2 diabetes Annals of Hepatology steatotic liver disease NAFLD (non-alcoholic fatty liver disease) NASH (non-alcoholic steatohepatitis) liver-related mortality adverse-liver outcomes liver disease |
| title | The rationale for the aggressive progression of MASLD in patients with type 2 diabetes |
| title_full | The rationale for the aggressive progression of MASLD in patients with type 2 diabetes |
| title_fullStr | The rationale for the aggressive progression of MASLD in patients with type 2 diabetes |
| title_full_unstemmed | The rationale for the aggressive progression of MASLD in patients with type 2 diabetes |
| title_short | The rationale for the aggressive progression of MASLD in patients with type 2 diabetes |
| title_sort | rationale for the aggressive progression of masld in patients with type 2 diabetes |
| topic | steatotic liver disease NAFLD (non-alcoholic fatty liver disease) NASH (non-alcoholic steatohepatitis) liver-related mortality adverse-liver outcomes liver disease |
| url | http://www.sciencedirect.com/science/article/pii/S1665268125000043 |
| work_keys_str_mv | AT valeriamichellefernandezgaribay therationalefortheaggressiveprogressionofmasldinpatientswithtype2diabetes AT norbertocchaveztapia therationalefortheaggressiveprogressionofmasldinpatientswithtype2diabetes AT valeriamichellefernandezgaribay rationalefortheaggressiveprogressionofmasldinpatientswithtype2diabetes AT norbertocchaveztapia rationalefortheaggressiveprogressionofmasldinpatientswithtype2diabetes |